DAVID RIOS: Open Payments
NPI 1265406334 · WAYCROSS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 12 payments from 10 companies in 2025. Trend: 2023 $443 · 2024 $570 · 2025 $357
Food & beverage: $329Speaker / faculty: $28
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $154 |
| Exact Sciences Corporation | 2 | $47 |
| Becton, Dickinson and Company | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Novo Nordisk Inc | 1 | $20 |
| EVOKE PHARMA, INC. | 1 | $20 |
| Abbott Laboratories | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| CashFlow Solutions, LLC | 1 | $15 |
| Antares Pharma, Inc. | 1 | $14 |
Products named: BREZTRI, The Cologuard Plus Collection Kit, AIRSUPRA, Power-Trialysis, SHINGRIX, Rybelsus, GIMOTI, PRODIGY.
Industry payments across GA — which companies pay providers there.
